# A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

> **NCT06683352** · PHASE1,PHASE2 · COMPLETED · sponsor: **BioNTech SE** · enrollment: 1353 (actual)

## Conditions studied

- Influenza,Human
- COVID-19

## Interventions

- **BIOLOGICAL:** Investigational Influenza Vaccine
- **BIOLOGICAL:** COVID-19 Vaccine
- **COMBINATION_PRODUCT:** Influenza and COVID Combination Vaccine
- **BIOLOGICAL:** Licensed Influenza Vaccine 1
- **BIOLOGICAL:** Licensed Influenza Vaccine 2
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06683352
- **Lead sponsor:** BioNTech SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-11
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-07-15
- **Target enrollment:** 1353 (ACTUAL)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683352, "A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06683352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*